Multiple sclerosis and Short-term memory loss - from FDA reports

Summary

Short-term memory loss is found among people with Multiple sclerosis, especially for people who are female, 50-59 old, take medication Tysabri and have Depression. This review analyzes which people have Short-term memory loss with Multiple sclerosis. It is created by eHealthMe based on reports of 21,170 people who have Multiple sclerosis from FDA , and is updated regularly.

What to expect?

If you have Multiple sclerosis and Short-term memory loss, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who have Multiple sclerosis and Short-term memory loss

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Sep, 20, 2017

21,170 people who have Multiple Sclerosis and Short-Term Memory Loss are studied.


Number of reports submitted per year:

Would you have Short-term memory loss when you have Multiple sclerosis?

Gender of people who have Multiple Sclerosis and experience Short-Term Memory Loss *:

  • female: 77.97 %
  • male: 22.03 %

Age of people who have Multiple Sclerosis and experience Short-Term Memory Loss *:

  • 0-1: 0.02 %
  • 2-9: 0.05 %
  • 10-19: 0.36 %
  • 20-29: 5.17 %
  • 30-39: 15.89 %
  • 40-49: 28.5 %
  • 50-59: 31.29 %
  • 60+: 18.71 %

Top co-existing conditions for these people *:

  • Depression (334 people, 1.58%)
  • Gait Disturbance (272 people, 1.28%)
  • Pain (269 people, 1.27%)
  • High Blood Pressure (185 people, 0.87%)
  • Stress And Anxiety (153 people, 0.72%)

Most common drugs for these people *:

  • Tysabri (8,261 people, 39.02%)
  • Avonex (7,557 people, 35.70%)
  • Tecfidera (2,859 people, 13.50%)
  • Gilenya (1,512 people, 7.14%)
  • Aubagio (917 people, 4.33%)

Top symptoms for these people *:

  • Fatigue (3,717 people, 17.56%)
  • Weakness (2,496 people, 11.79%)
  • Fall (2,323 people, 10.97%)
  • Gait Disturbance (2,290 people, 10.82%)
  • Multiple Sclerosis Relapse (2,144 people, 10.13%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have Short-term memory loss and Multiple sclerosis?

Expand the study to include reports from both FDA and eHealthMe

Short-term memory loss and Multiple sclerosis from FDA and eHealthMe reports

Multiple Sclerosis

Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) can be treated by Copaxone, Tysabri, Avonex, Rebif, Baclofen (latest reports from 463,870 Multiple sclerosis patients)

Short-Term Memory Loss

Short-term memory loss has been reported by people with multiple sclerosis, depression, pain, high blood pressure, high blood cholesterol (latest reports from 117,117 Short-term memory loss patients).

Browse all symptoms of Multiple sclerosis

a b c d e f g h i j k l m n o p q r s t u v w x y z

Could your drugs cause Short-term memory loss

Short-term memory loss

Other conditions that could case Short-term memory loss

Short-term memory loss

Related studies

What would happen?

Forecast new side effects and undetected conditions when you have Multiple sclerosis and Short-term memory loss.

Can you answer these questions?

More questions >

You may be interested in these reviews

More reviews >